Levin Zhu (L), CEO of China International Capital Corp. and son of former Chinese Premier Zhu Rongji, Song Zhiping (C), chairman of Sinopharm Group, and Ronald Arculli, chairman of Hong Kong Exchanges & Clearing Ltd., celebrate during the debut of Sinopharm Group Co. Ltd. at the Hong Kong Stock Exchange September 23, 2009. Shares of Sinopharm Group Co Ltd, China's top pharmaceutical products distributor, rose 23.4 percent in their Hong Kong debut on Wednesday, as investors bet on strong growth for China's healthcare sector. REUTERS/Bobby Yip (CHINA POLITICS BUSINESS)
REUTERS/BOBBY YIP